MovDisordV3, Main, Exploration, bibRecord, 004730

Parkinsonism after glycine‐derivate exposure

Identifieur interne : 004730 ( Main/Exploration ); précédent : 004729; suivant : 004731

Parkinsonism after glycine‐derivate exposure

Auteurs : Egberto R. Barbosa [Brésil] ; Maria D. Leiros Da Costa [Brésil] ; Luiz A. Bacheschi [Brésil] ; Milberto Scaff [Brésil] ; Claudia C. Leite [Brésil]

Source :

Movement Disorders [ 0885-3185 ] ; 2001-05.

RBID : ISTEX:A61CC955B1E29A4D83222CD652CB5C7A2692D31D

Descripteurs français

Pascal (Inist)
- Enregistrement vidéo, Etude cas, Glyphosate, Herbicide, Homme, Imagerie RMN, Intoxication, Pallidum, Parkinsonisme, Substance grise.
Wicri :
- topic : Herbicide, Homme.

English descriptors

KwdEn :
- Antiparkinson Agents (therapeutic use), Benserazide (therapeutic use), Case study, Drug Therapy, Combination, Globus Pallidus (pathology), Glycine (analogs & derivatives), Glycine (poisoning), Glyphosate, Grey matter, Herbicide, Herbicides (poisoning), Human, Humans, Levodopa (therapeutic use), Magnetic Resonance Imaging, Male, Middle Aged, Nuclear magnetic resonance imaging, Pallidum, Parkinson Disease, Secondary (chemically induced), Parkinson Disease, Secondary (drug therapy), Parkinson Disease, Secondary (pathology), Parkinsonism, Poisoning, Substantia Nigra (pathology), Video recording, Videotape Recording.
MESH :
- chemical , analogs & derivatives : Glycine.
- chemical , poisoning : Glycine, Herbicides.
- chemical , therapeutic use : Antiparkinson Agents, Benserazide, Levodopa.
- chemically induced : Parkinson Disease, Secondary.
- drug therapy : Parkinson Disease, Secondary.
- pathology : Globus Pallidus, Parkinson Disease, Secondary, Substantia Nigra.
- Drug Therapy, Combination, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Videotape Recording.

Abstract

This 54‐year‐old man accidentally sprayed himself with the chemical agent glyphosate, a herbicide derived from the amino acid glycine. He developed disseminated skin lesions 6 hours after the accident. One month later, he developed a symmetrical parkinsonian syndrome. Two years after the initial exposure to glyphosate, magnetic resonance imaging revealed hyperintense signal in the globus pallidus and substantia nigra, bilaterally, on T2‐weighted images. Levodopa/benserazide 500/125 mg daily provided satisfactory clinical outcome.

Url:

https://api.istex.fr/document/A61CC955B1E29A4D83222CD652CB5C7A2692D31D/fulltext/pdf

DOI: 10.1002/mds.1105

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Parkinsonism after glycine‐derivate exposure</title>
<author><name sortKey="Barbosa, Egberto R" sort="Barbosa, Egberto R" uniqKey="Barbosa E" first="Egberto R." last="Barbosa">Egberto R. Barbosa</name>
</author>
<author><name sortKey="Leiros Da Costa, Maria D" sort="Leiros Da Costa, Maria D" uniqKey="Leiros Da Costa M" first="Maria D." last="Leiros Da Costa">Maria D. Leiros Da Costa</name>
</author>
<author><name sortKey="Bacheschi, Luiz A" sort="Bacheschi, Luiz A" uniqKey="Bacheschi L" first="Luiz A." last="Bacheschi">Luiz A. Bacheschi</name>
</author>
<author><name sortKey="Scaff, Milberto" sort="Scaff, Milberto" uniqKey="Scaff M" first="Milberto" last="Scaff">Milberto Scaff</name>
</author>
<author><name sortKey="Leite, Claudia C" sort="Leite, Claudia C" uniqKey="Leite C" first="Claudia C." last="Leite">Claudia C. Leite</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A61CC955B1E29A4D83222CD652CB5C7A2692D31D</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1002/mds.1105</idno>
<idno type="url">https://api.istex.fr/document/A61CC955B1E29A4D83222CD652CB5C7A2692D31D/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001995</idno>
<idno type="wicri:Area/Istex/Curation">001995</idno>
<idno type="wicri:Area/Istex/Checkpoint">002F57</idno>
<idno type="wicri:doubleKey">0885-3185:2001:Barbosa E:parkinsonism:after:glycine</idno>
<idno type="wicri:Area/Main/Merge">006C12</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:01-0377476</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002998</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000323</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002938</idno>
<idno type="wicri:doubleKey">0885-3185:2001:Barbosa E:parkinsonism:after:glycine</idno>
<idno type="wicri:Area/Main/Merge">006E37</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:11391760</idno>
<idno type="wicri:Area/PubMed/Corpus">003D27</idno>
<idno type="wicri:Area/PubMed/Curation">003D27</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003C80</idno>
<idno type="wicri:Area/Ncbi/Merge">000524</idno>
<idno type="wicri:Area/Ncbi/Curation">000524</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000524</idno>
<idno type="wicri:doubleKey">0885-3185:2001:Barbosa E:parkinsonism:after:glycine</idno>
<idno type="wicri:Area/Main/Merge">006982</idno>
<idno type="wicri:Area/Main/Curation">004730</idno>
<idno type="wicri:Area/Main/Exploration">004730</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Parkinsonism after glycine‐derivate exposure</title>
<author><name sortKey="Barbosa, Egberto R" sort="Barbosa, Egberto R" uniqKey="Barbosa E" first="Egberto R." last="Barbosa">Egberto R. Barbosa</name>
<affiliation wicri:level="3"><country xml:lang="fr">Brésil</country>
<wicri:regionArea>Divisão de Clínica Neurológica, do Hospital das Clínicas da Faculdade, de Medicina da Universidade, de São Paulo, São Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Leiros Da Costa, Maria D" sort="Leiros Da Costa, Maria D" uniqKey="Leiros Da Costa M" first="Maria D." last="Leiros Da Costa">Maria D. Leiros Da Costa</name>
<affiliation wicri:level="3"><country xml:lang="fr">Brésil</country>
<wicri:regionArea>Divisão de Clínica Neurológica, do Hospital das Clínicas da Faculdade, de Medicina da Universidade, de São Paulo, São Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bacheschi, Luiz A" sort="Bacheschi, Luiz A" uniqKey="Bacheschi L" first="Luiz A." last="Bacheschi">Luiz A. Bacheschi</name>
<affiliation wicri:level="3"><country xml:lang="fr">Brésil</country>
<wicri:regionArea>Divisão de Clínica Neurológica, do Hospital das Clínicas da Faculdade, de Medicina da Universidade, de São Paulo, São Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Scaff, Milberto" sort="Scaff, Milberto" uniqKey="Scaff M" first="Milberto" last="Scaff">Milberto Scaff</name>
<affiliation wicri:level="3"><country xml:lang="fr">Brésil</country>
<wicri:regionArea>Divisão de Clínica Neurológica, do Hospital das Clínicas da Faculdade, de Medicina da Universidade, de São Paulo, São Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Leite, Claudia C" sort="Leite, Claudia C" uniqKey="Leite C" first="Claudia C." last="Leite">Claudia C. Leite</name>
<affiliation wicri:level="3"><country>Brésil</country>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
<wicri:orgArea>Departamento de Radiologia, da Faculdade de Medicina, da Universidade de São Paulo</wicri:orgArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>John Wiley & Sons, Inc.</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2001-05">2001-05</date>
<biblScope unit="vol">16</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="565">565</biblScope>
<biblScope unit="page" to="568">568</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">A61CC955B1E29A4D83222CD652CB5C7A2692D31D</idno>
<idno type="DOI">10.1002/mds.1105</idno>
<idno type="ArticleID">MDS1105</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (therapeutic use)</term>
<term>Benserazide (therapeutic use)</term>
<term>Case study</term>
<term>Drug Therapy, Combination</term>
<term>Globus Pallidus (pathology)</term>
<term>Glycine (analogs & derivatives)</term>
<term>Glycine (poisoning)</term>
<term>Glyphosate</term>
<term>Grey matter</term>
<term>Herbicide</term>
<term>Herbicides (poisoning)</term>
<term>Human</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nuclear magnetic resonance imaging</term>
<term>Pallidum</term>
<term>Parkinson Disease, Secondary (chemically induced)</term>
<term>Parkinson Disease, Secondary (drug therapy)</term>
<term>Parkinson Disease, Secondary (pathology)</term>
<term>Parkinsonism</term>
<term>Poisoning</term>
<term>Substantia Nigra (pathology)</term>
<term>Video recording</term>
<term>Videotape Recording</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Glycine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="poisoning" xml:lang="en"><term>Glycine</term>
<term>Herbicides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Benserazide</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Globus Pallidus</term>
<term>Parkinson Disease, Secondary</term>
<term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Videotape Recording</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Enregistrement vidéo</term>
<term>Etude cas</term>
<term>Glyphosate</term>
<term>Herbicide</term>
<term>Homme</term>
<term>Imagerie RMN</term>
<term>Intoxication</term>
<term>Pallidum</term>
<term>Parkinsonisme</term>
<term>Substance grise</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Herbicide</term>
<term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This 54‐year‐old man accidentally sprayed himself with the chemical agent glyphosate, a herbicide derived from the amino acid glycine. He developed disseminated skin lesions 6 hours after the accident. One month later, he developed a symmetrical parkinsonian syndrome. Two years after the initial exposure to glyphosate, magnetic resonance imaging revealed hyperintense signal in the globus pallidus and substantia nigra, bilaterally, on T2‐weighted images. Levodopa/benserazide 500/125 mg daily provided satisfactory clinical outcome.</div>
</front>
</TEI>
<affiliations><list><country><li>Brésil</li>
</country>
<region><li>État de São Paulo</li>
</region>
<settlement><li>São Paulo</li>
</settlement>
</list>
<tree><country name="Brésil"><region name="État de São Paulo"><name sortKey="Barbosa, Egberto R" sort="Barbosa, Egberto R" uniqKey="Barbosa E" first="Egberto R." last="Barbosa">Egberto R. Barbosa</name>
</region>
<name sortKey="Bacheschi, Luiz A" sort="Bacheschi, Luiz A" uniqKey="Bacheschi L" first="Luiz A." last="Bacheschi">Luiz A. Bacheschi</name>
<name sortKey="Leiros Da Costa, Maria D" sort="Leiros Da Costa, Maria D" uniqKey="Leiros Da Costa M" first="Maria D." last="Leiros Da Costa">Maria D. Leiros Da Costa</name>
<name sortKey="Leite, Claudia C" sort="Leite, Claudia C" uniqKey="Leite C" first="Claudia C." last="Leite">Claudia C. Leite</name>
<name sortKey="Scaff, Milberto" sort="Scaff, Milberto" uniqKey="Scaff M" first="Milberto" last="Scaff">Milberto Scaff</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004730 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004730 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:A61CC955B1E29A4D83222CD652CB5C7A2692D31D
   |texte=   Parkinsonism after glycine‐derivate exposure
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Parkinsonism after glycine‐derivate exposure

Parkinsonism after glycine‐derivate exposure

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.